Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue in septic cancer patients
NCT06005558Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in septic shock, sponsored by National Cancer Institute. Started Aug 2023; status: completed.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06005558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06005558.